Logo-ipp
Submitted: 07 Aug 2020
Accepted: 23 Oct 2020
ePublished: 14 Nov 2020
EndNote EndNote

(Enw Format - Win & Mac)

BibTeX BibTeX

(Bib Format - Win & Mac)

Bookends Bookends

(Ris Format - Mac only)

EasyBib EasyBib

(Ris Format - Win & Mac)

Medlars Medlars

(Txt Format - Win & Mac)

Mendeley Web Mendeley Web
Mendeley Mendeley

(Ris Format - Win & Mac)

Papers Papers

(Ris Format - Win & Mac)

ProCite ProCite

(Ris Format - Win & Mac)

Reference Manager Reference Manager

(Ris Format - Win only)

Refworks Refworks

(Refworks Format - Win & Mac)

Zotero Zotero

(Ris Format - Firefox Plugin)

Immunopathol Persa. 2021;7(2): e32.
doi: 10.34172/ipp.2021.32
  Abstract View: 205
  PDF Download: 138

Original

Treatment of chemotherapy induced anemia; a randomized clinical trial to compare quality of life in patients taking intravenous versus oral iron

Ali Hajigholami 1 ORCID logo, Ahmad-Reza Maghsoodi 2 ORCID logo, Hourieh Ansari 3 * ORCID logo, Marzieh Kafeshani 4

1 Department of Internal Medicine, Faculty of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran
2 Department of Internal Medicine, Faculty of Medicine, Shahrekord University of Medical Sciences, Shahrekord, Iran
3 Family and Community Medicine Department, Faculty of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran
4 School of Nutrition, Food Security Research Center, Isfahan University of Medical Sciences, Isfahan, Iran
*Correspondence to Hourieh Ansari, Houri_ansari@yahoo.com

Abstract

Introduction: Malignancy is one of the causes of anemia in chronic diseases. Anemia can commonly complicate the malignancy process.

Objectives: This study aimed to compare improvement in the quality of life and hemoglobin levels between cancer patients with chemotherapy-related anemia receiving erythropoietin and injectable iron supplement versus patients receiving erythropoietin and oral iron supplement.

Patients and Methods: This investigation was a randomized clinical trial carried out on 79 anemic individuals with metastatic and non-metastatic carcinoma who were undergoing chemotherapy. Individuals included in the study were randomly assigned to the two groups. The first group received erythropoietin and Venofer while the second group received erythropoietin and ferrous sulfate for 6 weeks. The quality of life for patients was assessed using the European Organization for Research and Treatment of Cancer quality of life questionnaire (EORTC QLQ-C30).

Results: Hemoglobin levels in both groups increased significantly while the difference between them was not significant. Despite improvement in more indexes of the questionnaire, post-treatment quality of life in both groups had no significant statistical difference (P>0.05). The changes in indices after interventions showed no difference between the oral and injectable iron supplements groups (P>0.05).

Conclusion: The results of this study showed that administration of erythropoietin and iron supplements, either orally or intravenously, even with a shorter duration of treatment could increase hemoglobin levels in chemotherapy-induced anemia group, however to improve the quality of life, it may be necessary to employ larger sample sizes and prolong treatment courses.

Trial registration: This randomized controlled trial was registered in the Thai Clinical Trials Registry (identifier: TCTR20200915003; http://www.clinicaltrials.in.th).

Keywords: Chemotherapy, Erythropoietin, Hemoglobin, Iron, Quality of life
Citation: Hajigholami A, Maghsoodi AR, Ansari H, Kafeshani M. Treatment of chemotherapy induced anemia; a randomized clinical trial to compare quality of life in patients taking intravenous versus oral iron. Immunopathol Persa. 2021;7(2):e32. DOI:10.34172/ ipp.2021.32.
First Name
 
Last Name
 
Email Address
 
Comments
 
Security code


Abstract View: 205

Your browser does not support the canvas element.


PDF Download: 138

Your browser does not support the canvas element.